nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A neonatal case of congenital blastic plasmacytoid dendritic cell neoplasm with KMT2C gene duplication
|
Li, Jian |
|
|
102 |
1 |
p. 227-229 |
artikel |
2 |
Anti-CD30 antibody–drug conjugate therapy in lymphoma: current knowledge, remaining controversies, and future perspectives
|
Prince, H. Miles |
|
|
102 |
1 |
p. 13-29 |
artikel |
3 |
A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy
|
Berdel, Andrew F. |
|
|
102 |
1 |
p. 63-72 |
artikel |
4 |
Bortezomib-based chemotherapy for patients with Waldenström macroglobulinemia: a single-center experience
|
Liu, Ziou |
|
|
102 |
1 |
p. 167-174 |
artikel |
5 |
CD19 CAR T-cell infusion during severe COVID-19 acute respiratory distress syndrome in large B-cell lymphoma
|
Buchtele, Nina |
|
|
102 |
1 |
p. 231-234 |
artikel |
6 |
Characteristics and outcomes of patients undergoing high-dose chemotherapy and autologous stem cell transplantation admitted to the intensive care unit: a single-center retrospective analysis
|
Garcia Borrega, Jorge |
|
|
102 |
1 |
p. 191-197 |
artikel |
7 |
Chronic active Epstein-Barr virus infection involving gastrointestinal tract with hemophagocytic lymphohistiocytosis
|
Shen, Kai |
|
|
102 |
1 |
p. 45-53 |
artikel |
8 |
Comparing the efficacy of salvage regimens for relapsed/refractory B-cell acute lymphoblastic leukaemia: a systematic review and network meta-analysis
|
Cao, Han-Yu |
|
|
102 |
1 |
p. 155-165 |
artikel |
9 |
Comparison of clinical characteristics of first-episode thrombotic thrombocytopenic purpura and TTP-like syndrome: a retrospective cohort study in a level I hematology center in China
|
Dong, Guiying |
|
|
102 |
1 |
p. 55-62 |
artikel |
10 |
Comparison of multiple treatments in the management of transplant-related thrombotic microangiopathy: a network meta-analysis
|
Yang, Jingyi |
|
|
102 |
1 |
p. 31-39 |
artikel |
11 |
Co-mutational pattern of somatic GATA2-mutated myeloid neoplasms
|
Katamesh, Bahga |
|
|
102 |
1 |
p. 211-212 |
artikel |
12 |
Cytogenetic evolution predicts a poor prognosis in acute myeloid leukemia patients who relapse after allogeneic hematopoietic stem cell transplantation
|
Li, Ruiqi |
|
|
102 |
1 |
p. 89-97 |
artikel |
13 |
Escalation to high‐flow nasal cannula oxygen in hematological malignancy: the right choice at the right moment?
|
Buonanno, Pasquale |
|
|
102 |
1 |
p. 221-222 |
artikel |
14 |
Evaluation of different pharmacokinetically guided IV busulfan exposure ranges on adult patient outcomes after hematopoietic stem cell transplantation
|
Mori, Shahram |
|
|
102 |
1 |
p. 181-190 |
artikel |
15 |
Excess deaths among adults with sickle cell disease in 2020 compared to prior years
|
Curtis, Susanna |
|
|
102 |
1 |
p. 41-44 |
artikel |
16 |
Feasibility of autologous peripheral blood stem cell mobilization and harvest in adult patients with FLT3-mutated acute myeloid leukemia receiving chemotherapy combined with midostaurin: a single-center experience
|
Cordella, Stefano |
|
|
102 |
1 |
p. 213-217 |
artikel |
17 |
Feasibility of electronic patient-reported outcome monitoring and self-management program in aplastic anemia and paroxysmal nocturnal hemoglobinuria—a pilot study (ePRO-AA-PNH)
|
Bänziger, Silas |
|
|
102 |
1 |
p. 199-208 |
artikel |
18 |
Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic
|
Obr, Ales |
|
|
102 |
1 |
p. 107-115 |
artikel |
19 |
Impact of tablet crushing on the dissolution of venetoclax
|
Yasu, Takeo |
|
|
102 |
1 |
p. 219-220 |
artikel |
20 |
Integrated single-cell transcriptome analysis of CD34 + enriched leukemic stem cells revealed intra- and inter-patient transcriptional heterogeneity in pediatric acute myeloid leukemia
|
Thakral, Deepshi |
|
|
102 |
1 |
p. 73-87 |
artikel |
21 |
Long-term complete remission of refractory severe idiopathic immune thrombocytopenia (ITP) treated with daratumumab
|
Strüßmann, Tim |
|
|
102 |
1 |
p. 245-247 |
artikel |
22 |
Monocytosis at the time of diagnosis has a negative prognostic impact in myelodysplastic syndromes with less than 5% bone marrow blasts
|
Kasprzak, A. |
|
|
102 |
1 |
p. 99-106 |
artikel |
23 |
Mutations in the plasma cell clone identify mechanism of polyneuropathy in a case of POEMS syndrome associated with Castleman disease and multiple myeloma
|
Brioli, Annamaria |
|
|
102 |
1 |
p. 239-242 |
artikel |
24 |
New-onset Evans syndrome in a patient with SLE post SARS-CoV2 mRNA vaccination
|
Ng, Timothy Y. M. |
|
|
102 |
1 |
p. 235-236 |
artikel |
25 |
Obinutuzumab and reduced bendamustine is effective for elderly patients with follicular lymphoma
|
Masamoto, Yosuke |
|
|
102 |
1 |
p. 243-244 |
artikel |
26 |
Performance status, comorbidities, and cycles of methotrexate exert the greatest influence on outcomes of primary and secondary CNS lymphomas: the Lexington experience
|
Curry, Lauren D. |
|
|
102 |
1 |
p. 141-154 |
artikel |
27 |
Platelet recovery with ibrutinib therapy in patient with treatment-refractory immune thrombocytopenia
|
Parish, Paul Christopher |
|
|
102 |
1 |
p. 237-238 |
artikel |
28 |
Polatuzumab vedotin plus bendamustine and rituximab (Pola-BR) was effective for neurolymphomatosis in a patient with refractory diffuse large B-cell lymphoma
|
Shinmura, Kohei |
|
|
102 |
1 |
p. 223-225 |
artikel |
29 |
Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma: a real-world data from Turkey
|
Dal, Mehmet Sinan |
|
|
102 |
1 |
p. 133-140 |
artikel |
30 |
Prognostic value of the nutritional risk index in patients with newly diagnosed multiple myeloma
|
Zhang, Limei |
|
|
102 |
1 |
p. 125-132 |
artikel |
31 |
Refractory hepatosplenic T-cell lymphoma was successfully treated with salvage allogeneic hematopoietic stem cell transplantation combined with enhanced myeloablative preconditioning
|
Huang, Wenqiu |
|
|
102 |
1 |
p. 175-180 |
artikel |
32 |
Remission of universal vitiligo after allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome
|
Zhai, Yingying |
|
|
102 |
1 |
p. 209-210 |
artikel |
33 |
The emerging therapeutic landscape of relapsed/refractory multiple myeloma
|
Tanenbaum, Benjamin |
|
|
102 |
1 |
p. 1-11 |
artikel |
34 |
VTd-PACE and VTd-PACE-like regimens are effective salvage therapies in difficult-to-treat relapsed/refractory multiple myeloma: a single-center experience
|
Ghandili, Susanne |
|
|
102 |
1 |
p. 117-124 |
artikel |